PAPAVERINE TEVA INJECTION Israel - English - Ministry of Health

papaverine teva injection

teva israel ltd - papaverine hydrochloride - solution for injection - papaverine hydrochloride 40 mg / 2 ml - papaverine - papaverine - antispasmodic in visceral spasm, e.g. gastrointestinal colic, biliary and urinary tract spasms. peripheral vascular disease with vasospastic element. vascular spasm associated with acute myocardial infarcion, angina pectoris, peripheral and pulmonary embolism.

Papaverine HCl Sterop 40 mg/2 ml inj. sol. i.v./i.m./s.c. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

papaverine hcl sterop 40 mg/2 ml inj. sol. i.v./i.m./s.c. amp.

laboratoires sterop sa-nv - papaverine hydrochloride 40 mg/2 ml - solution for injection - 40 mg/2 ml - papaverine hydrochloride 20 mg/ml - papaverine

DBL PAPAVERINE HYDROCHLORIDE 120mg/10mL Injection Australia - English - Department of Health (Therapeutic Goods Administration)

dbl papaverine hydrochloride 120mg/10ml injection

pfizer australia pty ltd - papaverine hydrochloride, quantity: 12 mg/ml - injection, solution - excipient ingredients: water for injections - papaverine hydrochloride injection is indicated for the treatment of erectile dysfunction.

Papaverine HCl Sterop 100 mg/3 ml inj. sol. i.v./i.m./s.c. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

papaverine hcl sterop 100 mg/3 ml inj. sol. i.v./i.m./s.c. amp.

laboratoires sterop sa-nv - papaverine hydrochloride 100 mg/3 ml - solution for injection - 100 mg/3 ml - papaverine hydrochloride 33.33 mg/ml - papaverine

PAPAVERINE HYDROCHLORIDE injection, solution United States - English - NLM (National Library of Medicine)

papaverine hydrochloride injection, solution

american regent, inc. - papaverine hydrochloride (unii: 23473ec6bq) (papaverine - unii:daa13nkg2q) - papaverine hydrochloride 30 mg in 1 ml - papaverine is recommended in various conditions accompanied by spasm of smooth muscle, such as vascular spasm associated with acute myocardial infarction (coronary occlusion), angina pectoris, peripheral and pulmonary embolism, peripheral vascular disease in which there is a vasospastic element, or certain cerebral angiospastic states; and visceral spasm, as in ureteral, biliary, or gastrointestinal colic. intravenous injection of papaverine is contraindicated in the presence of complete atrioventricular heart block. when conduction is depressed, the drug may produce transient ectopic rhythms of ventricular origin, either premature beats or paroxysmal tachycardia. papaverine hydrochloride is not indicated for the treatment of impotence by intracorporeal injection. the intracorporeal injection of papaverine hydrochloride has been reported to have resulted in persistent priapism requiring medical and surgical intervention. drug dependence resulting from the abuse of many of the selective depressants, includin

Papaverine 60 Namibia - English - Namibia Medicines Regulatory Council

papaverine 60

aspen pharmacare - papaverine hcll, solution for injection - injection - papaverine hcl 60mg/vial, solution for injection

DBL™ Papaverine Hydrochloride New Zealand - English - Medsafe (Medicines Safety Authority)

dbl™ papaverine hydrochloride

pfizer new zealand limited - papaverine hydrochloride 12 mg/ml - solution for injection - 120 mg/10ml - active: papaverine hydrochloride 12 mg/ml excipient: water for injection

PAPAVERINE HCL STEROP 40 MG2 ML Israel - English - Ministry of Health

papaverine hcl sterop 40 mg2 ml

raz pharmaceutics ltd, israel - papaverine hydrochloride - solution for injection - papaverine hydrochloride 40 mg / 2 ml - papaverine - antispasmodic in visceral spasm, e.g. gastrointestinal colic, biliary and urinary tract spasms. peripheral vascular disease with vasospastic element. vascular spasm associated with acute myocardial infarction, angina pectoris, peripheral and pulmonary embolism.